Home
Biofabri

Biofabri Market Share Analysis for June 2026

Biofabri was founded in 2008 with the strong vision of researching anddeveloping new vaccines and immunotherapy products for Human Health

Industry: N/A

Domainbiofabri.es

Year Founded2008

Employees51 - 200

Annual Revenue$5M - $10M

Biofabri

Biofabri (including company regionals)

biofabri.es

See more website traffic and engagement information

Biofabri Revenue up to June 2026 is 5M - 10M

revenue generated by Biofabri top domains

Biofabri top domains revenue over 3 years

Revenue for Biofabri top domains

biofabri.es5M - 10M

See more with Sales Intelligence

Total visits to Biofabri's top domains

Understand Biofabri market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

biofabri.es808

See more with Sales Intelligence

Avg. visit duration in Biofabri's top domains

Analyze Biofabri engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

biofabri.es00:00:43

See more with Sales Intelligence

Avg. pageviews on Biofabri's top domains

See how Biofabri keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

biofabri.es1.69

See more with Sales Intelligence

Biofabri top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Biofabri

These are the website technologies, by industry, used by Biofabri top domains

Widget (5)

Twemoji

Content Management System (2)

WordPress

Email Services (2)

Mailjet

Mobile (2)

Meta Viewport

More Technologies

5

See all

News & Signals from Biofabri

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiofabri partnered with Fundacaoataulphodepaiva on May 20th '26.* In response to the recurrent global shortage of BCG-based therapies, Biofabri took the initiative to collaborate with the Ataulpho de Paiva Foundation and develop an alternative aimed at expanding therapeutic options for bladder cancer patients.

NewsBiofabri hired Rolando Pajón on Feb 17th '26.Biofabri appoints Rolando Pajón to strengthen the late-stage development of its tuberculosis vaccine candidate.

NewsBharat Biotech partnered with Biofabri on Mar 1st '22.• In March 2022, Bharat Biotech announced a partnership with Biofabri, a Spanish biopharmaceutical company, to develop, manufacture and market a new tuberculosis vaccine 'MTBVAC'.